Prophylactic Antiviral Treatment in Recurrent Herpes Zoster: A Case Report

Bayram H. G. , Ozcan H., BAYINDIR Y.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, cilt.45, ss.56-59, 2011 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 45 Konu: 2
  • Basım Tarihi: 2011
  • Doi Numarası: 10.4274/turkderm.45.26
  • Sayfa Sayıları: ss.56-59


Herpes zoster (HZ) occurs in older ages with activation of varicella-zoster virus (VZV) which persists in a dormant phase within the dorsal root ganglia. The incidence of HZ in immunosuppressed patients is 20-100 times higher and the clinical progress is more severe than in immunocompetent individuals. A 48-year-old man who had been diagnosed with acute myelocytic leukemia type M3 and had been treated with immunosuppressive agents was admitted to our clinic. The patient was clinically diagnosed as having HZ. He was treated with acyclovir 800 mg five times daily for 7 days. In the consecutive three months, he attended our clinic again with similar complaints. The left cervical (C)5, C6 dermatomes were involved at the fourth attack of HZ. Multinucleated giant cells were determined on the Tzanck smear. VZV DNA was detected by polymerase chain reaction (PCR). Treatment with valacyclovir 1 g three times daily for 14 days was prescribed and then, prophylactic treatment with valacyclovir 500 mg two times a day was administered. Although immunosuppressive treatment was continued, no new attacks of herpes zoster occurred. We think that prophylactic antiviral therapy should be initiated in immunosuppressive individuals who have recurrent herpes zoster attacks.